Fecal transplant capsules for severe diarrhea after pancreatic surgery
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether taking capsules with healthy donor bacteria (fecal transplant) can help people who have severe diarrhea after surgery to remove part or all of the pancreas. The treatment aims to restore gut balance and reduce diarrhea.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have severe diarrhea linked to your recent pancreatic surgery.
- You are expected to live at least 3 more months.
- You have a performance status score of 1–3 (able to do some daily activities).
- You haven't taken broad-spectrum antibiotics by mouth or IV in the last 3 days.
- You can swallow capsules whole without chewing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a treatment called fecal microbiota transplant (FMT) — transferring healthy gut bacteria — can help relieve diarrhea and colitis caused by immunotherapy drugs. If you have melanoma or kidney cancer and are experiencing diarrhea after immunotherapy, this study may offer a new option.
This trial tests whether putting stool (fecal microbiota) from a donor into your bowel can improve symptoms in people with IBS who are not IBS-C. It may help by changing the gut bacteria that can influence IBS symptoms.
This trial tests whether a fecal transplant (transferring healthy gut bacteria from a donor) can help people with severe acute pancreatitis. It is for adults who are about 2 weeks past the onset of the disease and have started to recover but still have fluid buildup in the pancreas.
This trial tests whether a fecal transplant (a stool donation from a healthy person) can help patients with advanced stomach cancer respond better to treatment. If you qualify, you would receive the transplant through a colonoscopy, possibly along with other standard therapies.
This study tests whether giving patients healthy donor stool bacteria (fecal microbiota transplantation) can reduce or prevent nausea, diarrhea, and other stomach or bowel problems caused by cancer treatment. It is for people with extrapulmonary neuroendocrine tumors who have had gastrointestinal side effects during their first three treatment cycles.
This trial tests whether “washed microbiota transplant” (a treatment using processed gut bacteria) can improve malnutrition in adults who developed it after certain upper gut surgeries. It may help by restoring helpful gut bacteria, but you must meet several medical and safety checks.
Hear when a new Diarrhea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.